| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/17/1997 | DE19601385A1 Verfahren zur Amplifikation von Nukleinsäure A process for amplifying nucleic acid |
| 07/17/1997 | DE19601365A1 Nucleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind Nucleic acid molecules encoding enzymes from plants, which are involved in starch synthesis |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242965A1 Improved mutants of (2,5-dkg) reductase |
| 07/17/1997 | CA2242864A1 Stable biocatalysts for ester hydrolysis |
| 07/17/1997 | CA2242711A1 Delivery of bioactive compounds to an organism |
| 07/17/1997 | CA2242666A1 Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2242430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | CA2242340A1 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241185A1 Process for detecting and quantifying nucleic acid molecules |
| 07/17/1997 | CA2241175A1 Methods and compositions for diagnosis of hyperhomocysteinemia |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/17/1997 | CA2239366A1 Recombinase-mediated generation of adenoviral vectors |
| 07/17/1997 | CA2195124A1 Transformed yeast strains |
| 07/16/1997 | EP0784096A1 Method of detection of polymorphism and a loss of heterozygosity in a lung tumor suppressor gene |
| 07/16/1997 | EP0784095A2 Enhanced accummulation of trehalose in plants |
| 07/16/1997 | EP0784094A1 Ribozyme -snRNA chimeric molecules having a catalytic activity for nuclear RNAs |
| 07/16/1997 | EP0784093A1 Osteoprotegerin |
| 07/16/1997 | EP0784092A1 Sorbitol kinase, process for producing the same, and substantially pure microorganism |
| 07/16/1997 | EP0784059A1 Antigenic polypeptide of chlamydia pneumoniae |
| 07/16/1997 | EP0783893A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/16/1997 | EP0783695A1 Cell tests and diagnostic index for alzheimer's disease |
| 07/16/1997 | EP0783693A1 In vitro models of cns function and dysfunction |
| 07/16/1997 | EP0783588A1 Detection of hydrophobic amplification products by extraction into an organic phase |
| 07/16/1997 | EP0783586A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 07/16/1997 | EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 07/16/1997 | EP0783584A1 Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation |
| 07/16/1997 | EP0783583A1 Cytoplasmic tyrosine kinase |
| 07/16/1997 | EP0783582A1 PROCESS OF PRODUCING $g(b)-LACTAM ANTIBIOTICS APPLYING MICROORGANISMS WITH INCREASED LIGASE ACTIVITY |
| 07/16/1997 | EP0783581A1 Process for the production of secondary metabolites |
| 07/16/1997 | EP0783580A2 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
| 07/16/1997 | EP0783579A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 07/16/1997 | EP0783578A1 Yeast with modified permeability |
| 07/16/1997 | EP0783577A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/16/1997 | EP0783576A1 Human alpha 4? receptor subunit of the gaba-a receptor |
| 07/16/1997 | EP0783575A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/16/1997 | EP0783574A1 Method for detection of malfolded protein |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783572A1 Promoter for the receptor tyrosine kinase, tie |
| 07/16/1997 | EP0783571A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors |
| 07/16/1997 | EP0783570A1 Finderons and methods of their preparation and use |
| 07/16/1997 | EP0783569A1 Monoclonal antibody to human cardiac myoglobin |
| 07/16/1997 | EP0783568A1 Fibroblasts for the treatment of muscular disorders |
| 07/16/1997 | EP0783567A1 Human galactokinase gene |
| 07/16/1997 | EP0783527A1 Cathepsin o2 protease |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783525A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 07/16/1997 | EP0783524A1 Peptides and pharmaceutical compositions comprising them |
| 07/16/1997 | EP0783523A1 Gaba a? receptor epsilon subunit |
| 07/16/1997 | EP0783516A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783482A1 Cationic transport reagents |
| 07/16/1997 | EP0783321A1 Vr-2332 viral nucleotide sequence and methods of use |
| 07/16/1997 | EP0783317A1 Mimetics of senescent cell derived inhibitors of dna synthesis |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0783296A1 Novel compositions for the introduction of polyanionic materials into cells |
| 07/16/1997 | EP0691968B1 Acyclic nucleoside analogs and oligonucleotide sequences containing them |
| 07/16/1997 | EP0672174A4 Htlv-1 probes for use in solution phase sandwich hybridization assays. |
| 07/16/1997 | EP0642523B1 Ganglioside analogs |
| 07/16/1997 | EP0640139B1 Process for producing recombinant proteins in steptomycetes |
| 07/16/1997 | EP0625214A4 Cmv probes for use in solution phase sandwich hybridization assays. |
| 07/16/1997 | EP0613497B1 Lymphoid cd30-antigen |
| 07/16/1997 | EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 07/16/1997 | EP0584125B1 Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 07/16/1997 | EP0506666B1 Method for the production of catalytic rna in bacteria |
| 07/16/1997 | EP0452391B1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 07/16/1997 | CN1154718A Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression |
| 07/16/1997 | CN1154717A Hyperthermostable protease gene |
| 07/16/1997 | CN1154716A Method of cultivating bacteria producing proteins that are expressed in a temp. regulated manner |
| 07/15/1997 | US5648599 Gene conferring disease resistance to plants by responding to an avirulence gene in plant pathogens |
| 07/15/1997 | US5648598 Ornamental character of scented geraniums by genetic transformation |
| 07/15/1997 | US5648597 Genetic engineering |
| 07/15/1997 | US5648563 Retro-alpha-retinol derivative and uses of retro-alpha-retinol |
| 07/15/1997 | US5648482 Nucleic acid sequences of allele of gene coding for cytochrome isozyme and mutants |
| 07/15/1997 | US5648481 Gastrointestinal disorders |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648477 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648466 Method for detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto |
| 07/15/1997 | US5648459 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 07/15/1997 | US5648334 Methods of treatment using ciliary neurotrophic factor |
| 07/15/1997 | US5648273 Hepatic growth factor receptor is the MET proto-oncogene |
| 07/15/1997 | US5648267 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
| 07/15/1997 | US5648260 Immunoglobulins |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648253 Inhibitor-resistant urokinase |
| 07/15/1997 | US5648251 Method of transduction of cells with retroviral vectors |
| 07/15/1997 | US5648250 Tissue plasminogen activator |
| 07/15/1997 | US5648249 Increasing level of adpglucose pyrophosphorylase |
| 07/15/1997 | US5648247 Method for increasing the omega-hydroxylase activity in candida tropicals |
| 07/15/1997 | US5648245 Method for constructing an oligonucleotide concatamer library by rolling circle replication |
| 07/15/1997 | US5648244 Production, purification, cleavage and use of fusion peptides |
| 07/15/1997 | US5648243 Human serum albumin expression construct |
| 07/15/1997 | US5648242 Method of production of birch pollen allergen P14 |
| 07/15/1997 | US5648241 Conjugate vaccine against group B streptococcus |
| 07/15/1997 | US5648240 MHC II analog from Staphylococcus aureus |